Michael A. Solomon, MD
Staff Clinician and
Head, Cardiology Section
Critical Care Medicine Department
Senior Staff Physician
Cardiovascular and Pulmonary Branch
National Heart, Lung, and Blood Institute
BS, Brown University
MD, New York University
Back to Senior Staff Directory
Back to Main PAH Page
NIH Clinical Center Senior Staff
Michael A. Solomon, MD
Dr. Michael Solomon heads the Cardiology Section of the Clinical Center's (CC) Critical Care Medicine Department at the National Institutes of Health (NIH) and is co-director of the department's translational pulmonary arterial hypertension program. He is a senior staff member of both the Critical Care Medicine Department of the NIH CC and the Cardiovascular and Pulmonary Branch of the National Heart, Lung, and Blood Institute (NHLBI).
Dr. Solomon completed his undergraduate degree at Brown University and his medical degree at New York University School of Medicine. After a residency at University of Texas (UT) Southwestern Medical Center at Dallas, he completed a Critical Care Medicine fellowship at the NIH CC. He returned to UT Southwestern Medical Center to complete a second fellowship in Cardiovascular Diseases. Subsequently, he joined the cardiology faculty of UT Southwestern specializing in caring for patients with heart failure, pulmonary hypertension and heart transplantation. He returned to NIH in 2000, receiving a joint appointment in both the Critical Care Medicine Department, CC, and the Cardiovascular and Pulmonary Branch, NHLBI.
Dr. Solomon serves on Board of Tutors for the NIH Medical Research Scholars Program, and is the course coordinator for the Critical Care Medicine fourth year medical student clinical elective. He also currently serves as the activity director for the Maryland Chapter of the American College of Cardiology (ACC) and chairperson of their steering committee for the Mid-Atlantic Capital Cardiology Symposium as well as co-chair of the ACC Critical Care Cardiology working group.
Dr. Solomon's research focuses on (1) endothelial cell dysfunction in pulmonary arterial hypertension and (2) acute cardiac allograft cellular rejection.
Honors and Awards
NIH Director's Award (2015); Distinguished Service Award, American College of Cardiology (ACC) Maryland Chapter (2012); NIH Principal Clinical Investigator, Bench-to-Bedside Award (2011 and 2004); Member ACC Board of Governors (2011-2015); Secretary, Maryland Chapter of the ACC (2006-2011).
Agbor-Enoh ST, Tunc I, De Vlaminck I, Fideli U, Davis A, Cuttin K, Bhatti K, Marista A, Solomon MA, Jackson A, Graninger G, Harper B, Luikart H, Wylie J, Wang X, Khush K, Zhu J, and Valantine HA. Applying rigor and reproducibility standards to assay donor-derived cell-free DNA as a non-invasive method for detection of acute rejection and graft injury after heart transplantation. Journal of Heart & Lung transplantation. [Epub ahead of print] 2017.
van Diepen S, Fordyce CB, Wegermann Z, Granger CB, Stebbins A, Morrow DA, Solomon MA, Soble J, Henry TD, Gilchrist IC, Katz JN, Cohen MG, and Newby LK. Organizational structure, staffing, resources, and educational initiatives in cardiac intensive care units: A cross-sectional survey of on behalf of the AHA Acute Cardiac Care Committee and the ACC Critical Care Cardiology Working Group. Circulation: Cardiovascular Quality and Outcomes. 10 (8): 2017.
Awad KS, Elinoff JM, Wang S, Gairhe S, Ferreyra GA, Cai R, Sun J, Solomon MA, and Danner RL. Raf/ERK drives the proliferative and invasive phenotype of BMPR2-silenced pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol, 310(2): L187-201, 2016.
Tropea MM, Harper BJA, Graninger GM, Phillips TM, Ferreyra G, Mostowski H, Danner RL, Suffredini AF, and Solomon MA. Isolation of a Circulating CD45-, CD34dim Cell Population and Validation of their Endothelial Origin. Thrombosis and Haemostasis, 112(4): 770-80, 2014.
Elinoff JM, Forfia PR, Hall MK, Sun J, Gharib A, Abd-Elmoniem K, Graninger G, Harper B, Danner RL, and Solomon MA. A Pilot Study of the Effect of Spironolactone Therapy on Exercise Capacity and Endothelial Dysfunction in Pulmonary Arterial Hypertension. Trials, 14:91, 2013.
Chen H, Mei Yun-qing, and Solomon, MA. Experiences of Establishing a Rat Abdominal Heart Transplantation Model. National Medical Journal of China, 92(24):1715-18, 2012.
Amarnath S, Chen H, Foley JE, Costanzo CM, Sennesh JD, Solomon MA, and Fowler DH. Host-based Th2 Cell Therapy for Prolongation of Cardiac Allograft Viability. PloS ONE, 6(4): e18885, 2011.
Deans KJ, Minneci PC, Chen H, Kern SJ, Logun C, Alsaaty S, Norsworthy KJ, Theel SM, Sennesh JD, Barb JJ, Munson PJ, Danner RL, Solomon MA. Impact of animal strain on gene expression in a rat model of acute cardiac rejection. BMC Genomics 10: 280, 2009.
Solomon SB, Minneci PC, Deans KJ, Feng J, Eichacker PQ, Banks SM, Danner RL, Natanson C, Solomon MA. Effects of Intra-aortic Balloon Counterpulsation in a Model of Septic Shock. Critical Care Medicine 37(1):7-18, 2009.
Desai, A, Glaser, A, Liu, D, Raghavachari, N, Blum, A, Zalos, G, Lippincott, M, McCoy, JP, Munson, PJ, Solomon, MA, Danner, RL, Cannon, RO. Microarray-based characterization of a colony assay used to investigate endothelial progenitor cells and relevance to endothelial function in humans. Arterioscler Thromb Vasc Biol 29, 121-127, 2009.
Elshal MF, Khan SS, Raghavachari N, Takahashi Y, Barb J, Bailey JJ, Munson PJ, Solomon MA, Danner RL, McCoy JP. A unique population of effector memory lymphocytes identified by CD146 having a distinct immunophenotypic and genomic profile. BMC Immunology 8:29, 2007.
Elshal MF, Khan SS, Takahashi Y, Solomon MA, and McCoy JP. CD 146 (Mel-CAM), an adhesion marker of endothelial cells, is a novel marker of lymphocyte subset activation in normal peripheral blood. Blood. 106(8):2923-2924, 2005.
Khan SS, Solomon MA, and McCoy JP. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Clinical Cytometry. 64B (1):1-8, 2005.
NOTE: PDF documents require the free Adobe Reader.
This page last updated on 12/13/2017